# LICART
> **NDA206976** · New Drug Application · Sponsor: IBSA INST BIO · Approved 2018-12-19
## Drug
- **FDA Application Number:** NDA206976
- **Application type:** New Drug Application
- **Brand name:** LICART
- **Generic name:** DICLOFENAC EPOLAMINE
- **Active ingredients:** DICLOFENAC EPOLAMINE
- **Dosage form:** SYSTEM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** IBSA INST BIO
- **Manufacturer:** IBSA Pharma Inc.
- **First approval:** 2018-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206976)
---
*MORVS · CC0 1.0*